Raxone fachinformation
WebRaxone® (idebenone) is a drug that is thought to preserve mitochondrial function and it is believed that Raxone® can prevent cell damage and increase the production of energy … WebMar 12, 2024 · Raxone (idebenone), a synthetic short-chain benzoquinone and a cofactor for the enzyme NAD(P)H:quinone oxidoreductase (NQO1), has shown to promote recovery of visual acuity by circumventing the ...
Raxone fachinformation
Did you know?
Idebenone (pronounced eye-deb-eh-known, trade names Catena, Raxone, Sovrima, among others) is a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. This has been met with limited success. The Swiss company Santhera Pharmaceuticals has started to investigate it for the treatment of neu… WebNumărul autorizației de punere pe piață (UE) Numele (inventat) Concentrația Forma farmaceutică Calea de administrare Ambalajul primar Mărimea ambalajului EU/1/15/1020/001 Raxone 150 mg Comprimat filmat Administrare orală …
WebSep 9, 2024 · A total of 198 patients received treatment with Raxone and were included in the Safety Population. The mean duration of treatment in the Safety Population was … WebRaxone is a medicine used to treat visual impairment in adults and adolescents aged 12 years and over with Leber’s hereditary optic neuropathy (LHON), an inherited disease …
WebApr 21, 2015 · Gunnar M. Buyse, MD, PhD, Professor of Child Neurology at the University Hospitals Leuven (Belgium) and Principal Investigator for the DELOS trial, said, “Statistically significant and clinically relevant outcomes of primary and secondary endpoints coherently demonstrated that Raxone/Catena reduced the loss of respiratory function and that it was … WebJun 23, 2024 · Santhera Pharmaceuticals announces positive topline results from itslong-term Phase 4 LEROS study with Raxone® in the treatment of Leber’s hereditary optic …
WebBislang haben sechs Wirkstoffe der Augenheilkunde in elf Anwendungsgebieten die frühe Nutzenbewertung nach § 35a SGB V durchlaufen. Nur für einen Wirkstoff (Ocriplasmin) …
WebJun 23, 2024 · LEROS, a Phase 4 externally-controlled open-label intervention study, was designed to confirm the efficacy of Raxone in patients with LHON after 12 months of … direct elisa vs sandwichWebMay 24, 2024 · Santhera Pharmaceuticals (SIX: SANN) announces that it has entered into an exclusive license agreement with Chiesi Farmaceutici, an international research-focused healthcare group (Chiesi Group), under which Chiesi Group will in-license Raxone® for the treatment of LHON for a total consideration of up to CHF 105 million (EUR 93 million), … forty times aroundWebNov 8, 2024 · Below is a text only representation of the Patient Information Leaflet (ePIL). The text only version may be available in large print, Braille or audio CD . For further … direct elongation of radicle leads toWebRaxone is indicated for the treatment of Leber Optic Atrofy(LOA)/ Leber’s Hereditary Optic Neuropathy (LHON). The active ingredient in Raxone is idebenone. Idebenone is an … forty times tenWebMay 23, 2024 · Raxone (idebenone), a synthetic short-chain benzoquinone and a cofactor for the enzyme NAD(P)H:quinone oxidoreductase (NQO1), circumvents the complex I defect, reduces and scavenges ROS, restores ... forty three inch tvWebIntroduction: Leber's Hereditary Optic Neuropathy (LHON) causes a rapid and severe decrease in visual acuity. Raxone ® (Idebenone, Santhera) is the only drug to have a … direct electric boiler for small flatWebRaxone ist ein Arzneimittel zur Behandlung von Sehstörungen bei Erwachsenen und Jugendlichen ab 12 Jahren mit Leberscher hereditärer Optikusneuropathie (LHON), einer … forty times two